Literature DB >> 6418119

2-Chlorobenzylmercapturic acid, a metabolite of the riot control agent 2-chlorobenzylidene malononitrile (CS) in the rat.

E C Rietveld, L P Delbressine, T H Waegemaekers, F Seutter-Berlage.   

Abstract

Adult male Wistar rats administered i.p. with 2-chlorobenzylidene malononitrile (CS) excreted one mercapturic acid in urine. The amount of mercapturic acid determined gaschromatographically was about 4% of the dose (0.07 mmol/kg, n = 12). The structure of the mercapturic acid methylester was identified by t.l.c. and confirmed by synthesis and mass-spectrography. The acid appeared to be 2-chlorobenzylmercapturic acid [N-acetyl-S-(2-chlorobenzyl)-L-cysteine]. CS and some of its metabolites were also tested in the Ames Salmonella/microsome assay. Both mutagenic and toxic effects were measured with strain TA 100 as the indicator organism. No mutagenic effects were found with any of the tested substances. At dosages of CS, higher than 1,000 micrograms/plate a bacteriotoxicity was revealed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418119     DOI: 10.1007/BF01261382

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Biochemical studies of toxic agents. 11. The occurrence of premercapturic acids.

Authors:  R H KNIGHT; L YOUNG
Journal:  Biochem J       Date:  1958-09       Impact factor: 3.857

2.  The absorption of ortho-chlorobenzylidenemalononitrile (CS) by the respiratory tract.

Authors:  L Leadbeater
Journal:  Toxicol Appl Pharmacol       Date:  1973-05       Impact factor: 4.219

3.  Biochemical interactions and metabolic fate of riot control agents.

Authors:  S A Cucinell; K C Swentzel; R Biskup; H Snodgrass; S Lovre; W Stark; L Feinsilver; F Vocci
Journal:  Fed Proc       Date:  1971 Jan-Feb

4.  Industrial contact dermatitis. Effect of the riot control agent ortho-chlorobenzylidene malononitrile.

Authors:  E Shmunes; J S Taylor
Journal:  Arch Dermatol       Date:  1973-02

5.  Acute effects of exposure to orthochlorobenzylidene malononitrile (CS) and the development of tolerance.

Authors:  F W Beswick; P Holland; K H Kemp
Journal:  Br J Ind Med       Date:  1972-07

6.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

7.  A repeated dose study of the toxicity of inhaled 2-chlorobenzylidene malononitrile (CS) aerosol in three species of laboratory animal.

Authors:  T C Marrs; H F Colgrave; N L Cross; M F Gazzard; R F Brown
Journal:  Arch Toxicol       Date:  1983-03       Impact factor: 5.153

8.  Enzyme-catalysed conjugations of glutathione with unsaturated compounds.

Authors:  E Boyland; L F Chasseaud
Journal:  Biochem J       Date:  1967-07       Impact factor: 3.857

9.  Formation of mercapturic acids in rats after the administration of aralkyl esters.

Authors:  J J Clapp; L Young
Journal:  Biochem J       Date:  1970-08       Impact factor: 3.857

10.  Mechanism of formation of mercapturic acids from aromatic aldehydes in vivo.

Authors:  E C Rietveld; R Plate; F Seutter-Berlage
Journal:  Arch Toxicol       Date:  1983-03       Impact factor: 5.153

View more
  3 in total

1.  Mutagenicity and cytotoxicity of 2-chlorobenzylidene malonitrile (CS) and metabolites in V79 Chinese hamster cells.

Authors:  K Ziegler-Skylakakis; K H Summer; U Andrae
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Glutathione conjugation of chlorobenzylidene malononitriles in vitro and the biotransformation to mercapturic acids in rats.

Authors:  E C Rietveld; M M Hendrikx; F Seutter-Berlage
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

Review 3.  Exposure to the riot control agent CS and potential health effects: a systematic review of the evidence.

Authors:  Yiannis Dimitroglou; George Rachiotis; Christos Hadjichristodoulou
Journal:  Int J Environ Res Public Health       Date:  2015-01-27       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.